During the past decade, Ospedale Santa Maria delle Grazie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Santa Maria delle Grazie" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Gruppo di Ricerca GISSI" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Ipsen" with 1 trials sponsored and "Società Italiana di Cardiologia Invasiva" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Santa Maria delle Grazie" #1 collaborator was "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Royal Brompton & Harefield NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Santa Maria delle Grazie" are "Atrial Fibrillation" (2 trials), "Urinary Bladder Neoplasms" (2 trials), "Early-stage Breast Cancer" (1 trials), "Heart Failure" (1 trials) and "Metastatic Castrate Sensitive Prostate Cancer" (1 trials). Many other conditions were trialed in "Ospedale Santa Maria delle Grazie" in a lesser frequency.

Most popular intervention types in "Ospedale Santa Maria delle Grazie" are "Drug" (6 trials), "Biological" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetrelimab" (2 trials), "Placebo" (2 trials), "TAR-200" (2 trials), "Abiraterone acetate (AA)" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Santa Maria delle Grazie" are 6 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Santa Maria delle Grazie". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ospedale Santa Maria delle Grazie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Santa Maria delle Grazie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".